Antihypertensives

Antihypertensives

Hypertension Drugs

0 ratings
Free
In-App Purchases

Rating summary

Details

  • Released
  • Updated
  • April 29, 2026
  • June 3, 2026

Features

Antihypertensives screenshot #1 for iPhone
Antihypertensives screenshot #2 for iPhone
Antihypertensives screenshot #3 for iPhone
Antihypertensives screenshot #4 for iPhone
Antihypertensives screenshot #5 for iPhone
Antihypertensives screenshot #6 for iPhone
Antihypertensives screenshot #7 for iPhone
Antihypertensives screenshot #8 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

Antihypertensives — complete prescribing reference for antihypertensive drug classes, based on NICE NG136 and ESC/ESH 2023 guidelines. FREE TO TRY — no purchase needed: - ACE Inhibitors — ramipril, lisinopril, perindopril, doses, monitoring, side effects - Calcium Channel Blockers — amlodipine, felodipine, diltiazem, mechanism FULL ACCESS — £9.99 one-time purchase: Unlocks all sections including: - Angiotensin Receptor Blockers — losartan, candesartan, telmisartan - Beta-Blockers — bisoprolol, carvedilol, labetalol, heart failure and AF - Diuretics — indapamide, spironolactone, furosemide, thiazide-like - Other Agents — doxazosin, hydralazine, methyldopa, alpha-blockers - Compelling Indications — drug choice by comorbidity, diabetes, CKD, HF, AF, stroke, pregnancy - Resistant Hypertension — step 4 agents, spironolactone, renal denervation - References — NICE NG136, ESC/ESH 2023, landmark trials, all tappable One-time purchase. No subscription. Works fully offline. For qualified healthcare professionals only. Always verify doses against current BNF before prescribing.
Show more

What's New in Antihypertensives

1.0.2

June 3, 2026

Pricing now displays correctly in your local currency. Various improvements and fixes for a smoother experience.

1

In-App Purchases

$9.99

Antihypertensives — Full Access

All antihypertensive drug classes. Full access.

Developer apps